Clinical trial
Directly Observed Therapy in HIV Infected Adolescent Focus Groups
NCT00079729 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00079729 |
|---|---|
| Title | Directly Observed Therapy in HIV Infected Adolescent Focus Groups |
| Official title | Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 30 |
| Start date | Apr 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Mar 12, 2004 |
| Last update posted | Oct 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: